What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Seattle Genetics signs $4.4bn worth oncology deals with Merck US biotech company Seattle Genetics has secured deals worth up to $4.4 billion with Merck, that include two… bypharmanewsdailySeptember 14, 2020
